Calpainopathy Can Manifest Itself in Not Only Skeletal Muscle but Also the Brain and Myocardium. [PDF]
Finsterer J.
europepmc +1 more source
Key biomarkers and latent pathways of dysferlinopathy: Bioinformatics analysis and in vivo validation. [PDF]
Xie Y +7 more
europepmc +1 more source
A review of recent studies on CRISPR/Cas9-mediated genome editing in a variety of muscle-related genetic disorders. [PDF]
Lyu G, Li P, Lang W.
europepmc +1 more source
Serum metabolomic signatures of patients with rare neurogenetic diseases: an insight into potential biomarkers and treatment targets. [PDF]
Wijekoon N +12 more
europepmc +1 more source
Alternations of NF-κB Signaling by Natural Compounds in Muscle-Derived Cancers. [PDF]
Radzka J +5 more
europepmc +1 more source
Background : Limb girdle muscular dystrophy (LGMD) type 2A is caused by mutation in the gene encoding for calpain-3 resulting in total or partial loss of protein. Diagnosis of LGMD2A, the most prevalent form of LGMD, is established by analyzing calpain-3
Jha, Prerana +8 more
core
Progress on cell therapy for skeletal muscle disorders. [PDF]
Azzag K, Perlingeiro RCR.
europepmc +1 more source
Management of a 25-Year-Old Female Patient With Limb-Girdle Muscular Dystrophy With Physiotherapy: A Case Report. [PDF]
Nandanwar SP, Udhoji SP, Raghuveer R.
europepmc +1 more source
From 2D Myotube Cultures to 3D Engineered Skeletal Muscle Constructs: A Comprehensive Review of In Vitro Skeletal Muscle Models and Disease Modeling Applications. [PDF]
Cao T, Warren CR.
europepmc +1 more source
Integrating Machine Learning into Myositis Research: a Systematic Review. [PDF]
Juarez-Gomez C +8 more
europepmc +1 more source

